Exelixis to slash 160 jobs as prostate cancer trial fails
September 02, 2014 at 09:03 AM EDT
Once high-flying Exelixis Inc. will cut about 160 jobs after disclosing that its drug Cometriq failed a late-stage trial against a type of prostate cancer...